Hims & Hers Health, Inc. HIMS
Hims & Hers Health, Inc. financials (annual)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.3B | $1.5B | $872.0M | $526.9M | $271.9M | $148.8M | $82.6M |
| Gross profit | $1.7B | $1.2B | $714.9M | $408.7M | $204.5M | $109.5M | $44.6M |
| SG&A expense | — | — | — | — | $183.6M | $65.6M | $55.9M |
| Operating income | $105.6M | $61.9M | -$29.5M | -$68.7M | -$115.0M | -$15.1M | -$74.4M |
| Interest expense | — | — | — | — | $0 | $10,000 | $369,000 |
| Income tax | -$4.4M | -$54.3M | $2.0M | -$31,000 | -$3.1M | $127,000 | $90,000 |
| Net income | $128.4M | $126.0M | -$23.5M | -$65.7M | -$107.7M | -$18.1M | -$72.1M |
| EPS (diluted) | $0.51 | $0.53 | $-0.11 | $-0.32 | $-0.58 | $-0.51 | $-2.07 |
| Operating cash flow | $300.0M | $251.1M | $73.5M | -$26.5M | -$34.4M | -$2.5M | -$74.9M |
| Cash & equivalents | $228.6M | $220.6M | $96.7M | $46.8M | $71.8M | $27.3M | $1.5M |
| Inventory | $80.1M | $64.4M | $22.5M | $21.6M | $13.6M | $3.5M | — |
| Total assets | $2.2B | $707.5M | $441.2M | $366.3M | $420.6M | $118.7M | $204.8M |
| Total liabilities | $1.6B | $230.8M | $97.2M | $54.6M | $86.0M | $15.6M | $8.2M |
| Shareholders' equity | $540.9M | $476.7M | $344.0M | $311.7M | $334.6M | -$146.9M | -$139.8M |
Growth · year-over-year · Revenue CAGR 74.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue growth | +59.0% | +69.3% | +65.5% | +93.8% | +82.8% | +80.2% | — |
| Net income growth | +1.8% | — | — | — | — | — | — |
| EPS growth | -3.8% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.